Combination therapy with rofecoxib and finasteride in the treatment of men with lower urinary tract (LUTS) and benign prostatic hyperplasia (BPH)

被引：0

作者：

Sciarra, A

Cardi, A

Albanesi, L

Salvatori, G

Di Silverio, F

机构：

来源：

JOURNAL OF UROLOGY | 2004年 / 171卷 / 04期

关键词：

D O I：

10.1016/S0022-5347(18)38580-X

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：357 / 357

页数：1

共 50 条

[21] Impact of therapy used in clinical practice on lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) disease progression
Berges, R
EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 19 - 24
[22] Evidence for the efficacy and safety of tadalafil and finasteride in combination for the treatment of lower urinary tract symptoms and erectile dysfunction in men with benign prostatic hyperplasia
Olesovsky, Chris
Kapoor, Anil
THERAPEUTIC ADVANCES IN UROLOGY, 2016, 8 (04) : 257 - 271
[23] Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate
Ueckert, Stefan
Kedia, George T.
Tsikas, Dimitrios
Simon, Annika
Bannowsky, Andreas
Kuczyk, Markus A.
WORLD JOURNAL OF UROLOGY, 2020, 38 (06) : 1423 - 1435
[24] Impact of desmopressin on nocturia due to nocturnal polyuria in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Berges, Richard
Hoefner, Klaus
Gedamke, Michael
Oelke, Matthias
WORLD JOURNAL OF UROLOGY, 2014, 32 (05) : 1163 - 1170
[25] The total approach in lower urinary tract symptoms/benign prostatic hyperplasia (LUTS/BPH) management: Introduction and conclusions
Chapple, CR
EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (07) : 1 - 5
[26] Burden of male lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH) - focus on the UK
Speakman, Mark
Kirby, Roger
Doyle, Scott
Ioannou, Chris
BJU INTERNATIONAL, 2015, 115 (04) : 508 - 519
[27] Emerging drugs to target lower urinary tract symptomatology (LUTS)/benign prostatic hyperplasia (BPH): focus on the prostate
Stefan Ückert
George T. Kedia
Dimitrios Tsikas
Annika Simon
Andreas Bannowsky
Markus A. Kuczyk
World Journal of Urology, 2020, 38 : 1423 - 1435
[28] The efficacy and safety of ozarelix, a novel GNRH antagonist, in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH).
Debruyne, Frans M. J.
JOURNAL OF UROLOGY, 2007, 177 (04): : 512 - 512
[29] Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia (LUTS/BPH): More Than Treating Symptoms?
Speakman, Mark J.
EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (11) : 680 - 689
[30] Patient risk profiles for progression of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
Lowe, FC
EUROPEAN UROLOGY SUPPLEMENTS, 2004, 3 (04) : 7 - 11

← 1 2 3 4 5 →